Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  HIV Infection

  Free Subscription


Articles published in AIDS Res Hum Retroviruses

Retrieve available abstracts of 177 articles:
HTML format



Single Articles


    November 2021
  1. SABERI P, Campbell C, Lee EY, Guzman J, et al
    Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration.
    AIDS Res Hum Retroviruses. 2021 Nov 15. doi: 10.1089/AID.2021.0149.
    PubMed     Abstract available


  2. SUN-SUSLOW N, Balon E, Montoya JL, Saloner R, et al
    Frailty Syndrome is Associated with Poorer Self-Reported Sleep Quality Among Older Persons with Human Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2020.0158.
    PubMed     Abstract available


  3. JENNINGS L, Kellermann T, Spinelli MA, Nkantsu Z, et al
    Drug resistance, rather than low tenofovir levels in blood or urine, is associated with tenofovir, emtricitabine and efavirenz (TEE) failure in resource-limited settings.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0135.
    PubMed     Abstract available


  4. SCHIEFFER RJ, Bryndza Tfaily E, D'Aquila RT, Greene G, et al
    Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-exposure Prophylaxis (PrEP) for HIV.
    AIDS Res Hum Retroviruses. 2021 Nov 13. doi: 10.1089/AID.2021.0075.
    PubMed     Abstract available


    October 2021
  5. MADYADI A, Dhoro M, Shamu T, Washaya T, et al
    HIV-1 genetic diversity and natural polymorphisms of the integrase gene in integrase inhibitor naive patients in Harare, Zimbabwe.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0084.
    PubMed     Abstract available


  6. FURLER RL, Nixon DF
    HIV-1 Exploits Transitions Between CD4+ T Cell Migration and Activation.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0137.
    PubMed     Abstract available


  7. BROUILLETTE MJ, Koski L, Scott S, Austin-Keiller A, et al
    Factors influencing psychological distress during the COVID-19 pandemic in people aging with HIV.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0024.
    PubMed     Abstract available


  8. HIRANSUTHIKUL A, Chutinet A, Sophonphan J, Ubolyam S, et al
    Incidence and risk factors of ischemic stroke and transient ischemic attack among people living with HIV: a longitudinal cohort study.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0046.
    PubMed     Abstract available


  9. WALLNER J, Beck IA, Panpradist N, Ruth PS, et al
    Rapid, Near Point-of-Care Assay for HLA-B*57:01 Genotype Associated with Severe Hypersensitivity Reaction to Abacavir.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0103.
    PubMed     Abstract available


  10. LAHER F, Richardson SI, Smith P, Sullivan P, et al
    HIV prevention in a time of COVID-19: A report from the HIVR4P // Virtual conference 2021.
    AIDS Res Hum Retroviruses. 2021 Oct 29. doi: 10.1089/AID.2021.0138.
    PubMed     Abstract available


  11. GALAVIZ KI, Shah S, Gutierrez M, Collins LF, et al
    Patient Experiences with Telemedicine for HIV Care during the first COVID-19 Wave in Atlanta, Georgia.
    AIDS Res Hum Retroviruses. 2021 Oct 23. doi: 10.1089/AID.2021.0109.
    PubMed     Abstract available


  12. KURLE S, Kandaswami S, Gadhe S, Patil A, et al
    HIV-1 Drug Resistance among treatment naive Transgenders from India.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0157.
    PubMed     Abstract available


  13. KUSAGAWA S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, et al
    Nucleotide sequence of HIV-1-positive specimen reference panel for evaluation of HIV in-vitro diagnostics in Japan.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0160.
    PubMed     Abstract available


  14. PEREIRA B, Mazzitelli M, Milinkovic A, Moyle G, et al
    Predictive value of HIV-related versus traditional risk factors for coronary atherosclerosis in people aging with HIV.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0064.
    PubMed     Abstract available


  15. KIERI O, Marrone G, Sonnerborg A, Nowak P, et al
    Incidence, treatment and outcome of HIV-associated hematologic malignancies in people living with HIV in Sweden.
    AIDS Res Hum Retroviruses. 2021 Oct 15. doi: 10.1089/AID.2021.0020.
    PubMed     Abstract available


  16. SNEDECOR SJ
    Short Communication: Prevalence of Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors in European and North American Countries Over 20 Years: An Updated Meta-Analysis.
    AIDS Res Hum Retroviruses. 2021;37:751-753.
    PubMed     Abstract available


    September 2021
  17. JIANG JY, Reid E
    Impact of Insurance Status on Outcomes in Individuals with AIDS-Defining Cancers.
    AIDS Res Hum Retroviruses. 2021 Sep 29. doi: 10.1089/AID.2021.0102.
    PubMed     Abstract available


  18. YABAR CA, Vilcarino GF, Espetia S, Lujan F, et al
    Social, epidemiological, and virological characteristics from Peruvian subjects living with HIV-1 / AIDS with different sexual risk behavior.
    AIDS Res Hum Retroviruses. 2021 Sep 25. doi: 10.1089/AID.2021.0067.
    PubMed     Abstract available


  19. GUTHRIE KM, Rosen RK, Guillen M, Ramirez JJ, et al
    Designing dual compartment HIV prevention products: Women's sensory perceptions and experiences of suppositories for rectal and vaginal use.
    AIDS Res Hum Retroviruses. 2021 Sep 21. doi: 10.1089/AID.2021.0038.
    PubMed     Abstract available


  20. SARKAR S, Haberlen S, Post WS, Kelesidis T, et al
    Short Communication: Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/aid.2021.0035.
    PubMed     Abstract available


  21. STIRES H, LaMori J, Chow W, Zalewski Z, et al
    Weight Gain and Related Co-Morbidities Following Antiretroviral Initiation in the 2000s: A Systematic Literature Review.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2020.0216.
    PubMed     Abstract available


  22. MCGOWAN IM, Kunjara Na Ayudhya RP, Brand RM, Marzinke MA, et al
    An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0115.
    PubMed     Abstract available


  23. THET D, Siritientong T, Sangarlangkarn A, Mar Su Lwin H, et al
    Deterioration of nutritional status and its negative association with depression among older HIV-infected Asian population: a four-year longitudinal study.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0087.
    PubMed     Abstract available


  24. MCMANUS KA, Schurman E, An Z, Van Hook R, et al
    Patient Perspective of People with HIV who Gained Medicaid through Medicaid Expansion: A Cross-sectional Qualitative Study.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0129.
    PubMed     Abstract available


  25. BOUCHARD A, Bourdeau F, Roger J, Taillefer VT, et al
    Predictive Factors of Detectable Viral Load in HIV Infected Patients.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2021.0106.
    PubMed     Abstract available


  26. ALVES CGB, Assis MS, Maciel ADS, da Silva JC, et al
    Clinical and laboratory profile of people living with HIV/AIDS with oral Kaposi sarcoma.
    AIDS Res Hum Retroviruses. 2021 Sep 20. doi: 10.1089/AID.2020.0311.
    PubMed     Abstract available


  27. CRANSTON RD, Brown E, Bauermeister J, Dunne EF, et al
    A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026).
    AIDS Res Hum Retroviruses. 2021 Sep 9. doi: 10.1089/AID.2021.0071.
    PubMed     Abstract available


  28. AL-KOUATLY HB, Scott R, Makhamreh M, Cunningham G, et al
    Metabolomics in placental tissue from women living with HIV.
    AIDS Res Hum Retroviruses. 2021 Sep 9. doi: 10.1089/AID.2021.0056.
    PubMed     Abstract available


    August 2021
  29. GREENBERG AE, Celentano D, Metzger D, Magnus M, et al
    The Mid-Atlantic Centers for AIDS Research (CFAR) Consortium (MACC): Promoting HIV Science through Regional Collaboration.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0017.
    PubMed     Abstract available


  30. HERNANDEZ-FAVELA CG, Hernandez-Ruiz VA, Bello-Chavola OY, Crabtree-Ramirez B, et al
    Higher Veterans Aging Cohort Study (VACS) 2.0 Index Scores Predicts Functional Decline among Older Adults Living with HIV.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2020.0295.
    PubMed     Abstract available


  31. HAN L, Li H, Wang L, Jia L, et al
    Near Full-Length Genomic Characterization of Two Novel HIV-1 Unique Recombinant Forms (CRF01_AE/CRF07_BC) Among MSM in Shijiazhuang City, Hebei Province, China.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0100.
    PubMed     Abstract available


  32. CHEN YT, Li ZX, Xie YN, Zhao L, et al
    Genetic characterization of a novel HIV-1 second-generation recombinant form originating from CRF86_BC and a unique recombinant form in Yunnan, China.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0121.
    PubMed     Abstract available


  33. CARD CM, Abrenica B, McKinnon LR, Ball TB, et al
    Endothelial cells promote productive HIV infection of resting CD4+ T cells by an integrin-mediated cell adhesion-dependent mechanism.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0034.
    PubMed     Abstract available


  34. ARANCON PARDO A, Moreno Palomino M, Jimenez-Nacher I, Moreno F, et al
    REAL-WORLD EXPERIENCE WITH TWO-DRUG REGIMENS IN HIV-1 INFECTED PATIENTS BEYOND THE INDICATION OF CLINICAL TRIALS: 48 WEEKS RESULTS.
    AIDS Res Hum Retroviruses. 2021 Aug 31. doi: 10.1089/AID.2021.0041.
    PubMed     Abstract available


  35. KAMKWALALA AR, Garg A, Roy U, Matthews A, et al
    Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV & Aging Workshop.
    AIDS Res Hum Retroviruses. 2021 Aug 18. doi: 10.1089/AID.2021.0059.
    PubMed     Abstract available


  36. MCGOWAN IM, Chawki S, Hendrix CW, Anton PA, et al
    A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study).
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0096.
    PubMed     Abstract available


  37. DOOLAN B, Yeon J, Baker D, Whitfeld M, et al
    Dupilumab therapy for atopic dermatitis in people living with HIV.
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0113.
    PubMed     Abstract available


  38. SARKAR S, Haberlen S, Post W, Kelesidis T, et al
    Plasma Lymphocyte Activation Gene 3 and Subclinical Coronary Artery Disease in the Multicenter AIDS Cohort Study.
    AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0035.
    PubMed     Abstract available


    July 2021
  39. WELLER KG, Evans LK, Shinagawa A, Murtagh A, et al
    Missed Testing Opportunities Among HIV-Positive Adults in a Community Emergency Department.
    AIDS Res Hum Retroviruses. 2021 Jul 27. doi: 10.1089/AID.2020.0229.
    PubMed     Abstract available


  40. YAN J, Luo L, Han J, Yan D, et al
    Comparing non-invasive predictors of neurosyphilis among syphilis patients with and without HIV co-infection based on the real-world diagnostic criteria: a single-centre, retrospective cohort study in China.
    AIDS Res Hum Retroviruses. 2021 Jul 27. doi: 10.1089/AID.2021.0085.
    PubMed     Abstract available


  41. PEREIRA B, Mazzitelli M, Milinkovic A, Casley C, et al
    Evaluation of a clinic dedicated to people aging with HIV at Chelsea and Westminster Hospital: results of a 10-year experience.
    AIDS Res Hum Retroviruses. 2021 Jul 16. doi: 10.1089/AID.2021.0083.
    PubMed     Abstract available


  42. KASAHARA T, Imahashi M, Hashiba C, Mori M, et al
    Retrospective analysis of the efficacy of early antiretroviral therapy in HIV-1-infected patients coinfected with Pneumocystis jirovecii.
    AIDS Res Hum Retroviruses. 2021 Jul 8. doi: 10.1089/AID.2021.0025.
    PubMed     Abstract available


    June 2021
  43. YAO Y, Zeng Y, Huang H, Li J, et al
    Characteristics of four novel recombinant strains from the backbone of CRF55_01B and CRF65_cpx in Beijing by near full-length genome.
    AIDS Res Hum Retroviruses. 2021 Jun 24. doi: 10.1089/AID.2020.0255.
    PubMed     Abstract available


  44. WILBOURN B, Saafir-Callaway B, Jair K, Wertheim JO, et al
    Characterization of HIV Risk Behaviors and Clusters Using HIV-TRACE among a Cohort of Persons Living with HIV in Washington, DC.
    AIDS Res Hum Retroviruses. 2021 Jun 22. doi: 10.1089/AID.2021.0031.
    PubMed     Abstract available


  45. QUILES N, Ortiz A
    Prevalence of Cardiometabolic Risk Factors Among People Living with HIV in Southern Texas.
    AIDS Res Hum Retroviruses. 2021 Jun 17. doi: 10.1089/AID.2021.0019.
    PubMed     Abstract available


  46. OGOLA BO, Matume ND, Mavhandu LG, Tebit DM, et al
    Drug resistance mutations in a population prior to antiretroviral therapy initiation in Northern South Africa.
    AIDS Res Hum Retroviruses. 2021 Jun 9. doi: 10.1089/AID.2021.0026.
    PubMed     Abstract available


  47. CAPOFERRI AA, Redd AD, Gocke CD, Clark LR, et al
    Persistence of HIV after allogeneic bone marrow transplant in a dually-infected individual.
    AIDS Res Hum Retroviruses. 2021 Jun 9. doi: 10.1089/AID.2021.0047.
    PubMed     Abstract available


  48. HOU Z, Tan J, Jiang Y, Zhang L, et al
    Characterization and Recombinant genotypes of HIV-1 in Gansu Province, China.
    AIDS Res Hum Retroviruses. 2021 Jun 9. doi: 10.1089/AID.2021.0008.
    PubMed     Abstract available


  49. DE MENDOZA C, Caballero E, Eiros JM, Rojo S, et al
    Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain.
    AIDS Res Hum Retroviruses. 2021 Jun 3. doi: 10.1089/AID.2021.0013.
    PubMed     Abstract available


  50. CALEB-ADEPOJU SO, Dawit R, Gbadamosi SO, Sheehan DM, et al
    Factors Associated with Viral Suppression among Racial/Ethnic Minority Women in the Miami-Dade County Ryan White Program, 2017.
    AIDS Res Hum Retroviruses. 2021 Jun 3. doi: 10.1089/AID.2021.0039.
    PubMed     Abstract available


  51. OLUSOLA FI, Olusola BA, Oladokun R, Falade CO, et al
    SURVEILLANCE OF PRE-TREATMENT DRUG RESISTANCE AMONG HIV INFECTED CHILDREN IN IBADAN, OYO STATE, NIGERIA.
    AIDS Res Hum Retroviruses. 2021 Jun 2. doi: 10.1089/AID.2020.0272.
    PubMed     Abstract available



  52. Retraction of: Human Immunodeficiency Virus (HIV) and Outcomes from Coronavirus Disease 2019 (COVID-19) Pneumonia: A Meta-Analysis and Meta-Regression (doi: 10.1089/aid.2020.0307).
    AIDS Res Hum Retroviruses. 2021;37:503.
    PubMed    


    May 2021
  53. OLIVEIRA RC, Graf T, Rego FFA, Silva GPSA, et al
    Dynamic dispersion of HIV-1 Subtype C towards Brazilian northeastern region.
    AIDS Res Hum Retroviruses. 2021 May 26. doi: 10.1089/AID.2020.0308.
    PubMed     Abstract available


  54. MAYER S, Rayeed N, Novak RM, Li J, et al
    INSTI-BASED INITIAL ANTIRETROVIRAL THERAPY IN ADULTS WITH HIV, THE HIV OUTPATIENT STUDY, 2007-2018.
    AIDS Res Hum Retroviruses. 2021 May 25. doi: 10.1089/AID.2020.0286.
    PubMed     Abstract available


  55. DE PAZ-SILAVA SLM, Victoriano-Belvis AFB, Gloriani NG, Hibi Y, et al
    In vitro antiviral activity of Mentha cordifolia plant extract in HIV-1 latently infected cells using an established human cell line.
    AIDS Res Hum Retroviruses. 2021 May 25. doi: 10.1089/AID.2021.0053.
    PubMed     Abstract available


  56. NG QR, Tee KK, Binley JM, Tong T, et al
    Cross-neutralizing CRF01_AE-infected Plasma from Malaysia Targets CD4-binding Site of Human Immunodeficiency Virus Type-1 (HIV-1) Envelope Glycoprotein.
    AIDS Res Hum Retroviruses. 2021 May 18. doi: 10.1089/AID.2020.0299.
    PubMed     Abstract available


  57. HIRANSUTHIKUL A, Chutinet A, Suwanwela N
    Ischemic stroke subtypes among Thai HIV-infected patients: a 12-year retrospective study.
    AIDS Res Hum Retroviruses. 2021 May 18. doi: 10.1089/AID.2021.0003.
    PubMed     Abstract available


  58. MOUNZER K, Brunet L, Hsu R, Fusco JS, et al
    Changes in BMI associated with antiretroviral regimen switch among treatment-experienced, virologically suppressed people living with HIV in the United States.
    AIDS Res Hum Retroviruses. 2021 May 18. doi: 10.1089/AID.2020.0287.
    PubMed     Abstract available


  59. LATINI A, Dona MG, Giuliani M, Ancona C, et al
    HIV viral load trends during the COVID-19 pandemic in a reference center for HIV in Rome, Italy.
    AIDS Res Hum Retroviruses. 2021 May 8. doi: 10.1089/AID.2021.0044.
    PubMed     Abstract available


  60. MILLER ES, Garcia PM, Sutton SH, Jackson J, et al
    Getting to Zero: A Demonstration Project of Partner HIV Testing in the Prenatal Setting in Chicago, Illinois.
    AIDS Res Hum Retroviruses. 2021 May 7. doi: 10.1089/aid.2020.0122.
    PubMed     Abstract available


  61. KLEINMAN A, Sivanandham R, Sette P, Brocca-Cofano E, et al
    Lack of Specific Regulatory T-Cell Depletion and Cytoreduction Associated with Extensive Toxicity after Administration of Low and High Doses of Cyclophosphamide.
    AIDS Res Hum Retroviruses. 2021 May 6. doi: 10.1089/AID.2021.0036.
    PubMed     Abstract available


  62. DUBE K, Kanazawa JT, Campbell C, Boone CA, et al
    Considerations for Increasing Racial, Ethnic, Gender and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
    AIDS Res Hum Retroviruses. 2021 May 5. doi: 10.1089/AID.2021.0023.
    PubMed     Abstract available


    April 2021
  63. XING Y, Guo Y, Wang L, Li H, et al
    Identification of two Novel HIV-1 Second-generation Recombinant Forms (CRF01_AE/CRF07_BC) in Hebei, China.
    AIDS Res Hum Retroviruses. 2021 Apr 30. doi: 10.1089/AID.2021.0057.
    PubMed     Abstract available


  64. WANG L, Shao C, Lu L, Liu J, et al
    A longitudinal case study of concurrent infection with Syphilis and HIV during the early phase.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0281.
    PubMed     Abstract available


  65. ROMANO JW, Baum M, Demkovich ZR, Diana F, et al
    Tenofovir Alafenamide (TAF) for HIV Prevention: Review of the Proceedings from the Gates Foundation Long Acting (LA) TAF Product Development Meeting.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0028.
    PubMed     Abstract available


  66. YE DQ, Ashuro AA, Fan YG, Fu YS, et al
    The Effect of Rosuvastatin on plasma/serum levels of high sensitivity C-reactive protein, Interleukin-6 and D-dimer in people living with Human Immunodeficiency Virus: a systematic review and meta-analysis.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0273.
    PubMed     Abstract available


  67. PUJARI S, Gaikwad S, Chitalikar A, Dabhade D, et al
    CORONAVIRUS DISEASE 19 AMONGST PEOPLE LIVING WITH HIV IN WESTERN INDIA: AN OBSERVATIONAL COHORT STUDY.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0004.
    PubMed     Abstract available


  68. IBRAHIM ME, Glidden DV, Grant RM, Anderson PL, et al
    Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure Prophylaxis.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0032.
    PubMed     Abstract available


  69. SIYAN C, Qihua X, Jian W, Xinghua T, et al
    Effects of artesunate tablet on immune activation and reconstitution among HAART-treated patients with incomplete immune responses.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0254.
    PubMed     Abstract available


  70. KOECH E, Stafford KA, Mutysia I, Katana A, et al
    Factors Associated with Loss to Follow-up among Patients Receiving HIV Treatment in Nairobi, Kenya.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2020.0292.
    PubMed     Abstract available


  71. VIZCARRA P, Cabello A, Moreno A, Vivancos MJ, et al
    Progression risk in people with HIV and COVID-19: Predictive performance of current risk scores.
    AIDS Res Hum Retroviruses. 2021 Apr 29. doi: 10.1089/AID.2021.0012.
    PubMed     Abstract available


  72. BECKWITH C, Min S, Manne A, Novitsky V, et al
    HIV drug resistance and transmission networks among a justice-involved population at the time of community re-entry in Washington D.C.
    AIDS Res Hum Retroviruses. 2021 Apr 25. doi: 10.1089/AID.2020.0267.
    PubMed     Abstract available


  73. SHERMAN KE, Kottilil S, Rouster SD, Abdel-Hameed EA, et al
    Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons.
    AIDS Res Hum Retroviruses. 2021 Apr 1. doi: 10.1089/AID.2020.0303.
    PubMed     Abstract available


    March 2021
  74. DILLON SM, Abdo MH, Wilson MP, Liu J, et al
    A Unique Gut Microbiome-Physical Function Axis Exists In Older People With HIV: An Exploratory Study.
    AIDS Res Hum Retroviruses. 2021 Mar 31. doi: 10.1089/AID.2020.0283.
    PubMed     Abstract available


  75. RODRIGUEZ-CASTANON JM, McNaugthon A, Cardenas-Ochoa A, Fuentes-Romero LL, et al
    Exceptional T CD4+ recovery post-ART is linked to a lower HIV reservoir with a specific immune differentiation pattern.
    AIDS Res Hum Retroviruses. 2021 Mar 28. doi: 10.1089/AID.2020.0270.
    PubMed     Abstract available


  76. BUCHBINDER MH, Blue C, Brown ME, Bradley-Bull S, et al
    Jail-based Data-to-Care to Improve Continuity of HIV Care: Perspectives and Experiences from Previously Incarcerated Individuals.
    AIDS Res Hum Retroviruses. 2021 Mar 25. doi: 10.1089/AID.2020.0296.
    PubMed     Abstract available


  77. KAMORI D, Hasan Z, Carlson J, Kawana-Tachikawa AI, et al
    Impact of human leukocyte antigen-associated polymorphisms on variability of HIV-1 accessory and regulatory proteins.
    AIDS Res Hum Retroviruses. 2021 Mar 24. doi: 10.1089/AID.2021.0055.
    PubMed     Abstract available


  78. CHENG SW, Chen YP, Qi F, Gao R, et al
    Genetic characterization of a novel HIV-1 second-generation recombinant form (CRF01_AE/07_BC) identified in Yan`an city, China.
    AIDS Res Hum Retroviruses. 2021 Mar 24. doi: 10.1089/AID.2021.0058.
    PubMed     Abstract available


  79. KAPELIOS CJ, Masouris G, Argyris A, Konstantinidis I, et al
    Detection of subclinical coronary artery lesions by Framingham risk score, peripheral artery atheromatosis and coronary artery calcium score: a pilot study in asymptomatic individuals living with HIV.
    AIDS Res Hum Retroviruses. 2021 Mar 22. doi: 10.1089/AID.2021.0015.
    PubMed     Abstract available


  80. MCGOWAN IM, Tzakis N, Kosak B, Korczak B, et al
    Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers.
    AIDS Res Hum Retroviruses. 2021 Mar 22. doi: 10.1089/AID.2021.0010.
    PubMed     Abstract available


  81. MACDONALD DM, Collins G, Wendt CH, Wolfson J, et al
    A pilot study of the effects of losartan vs. placebo on pneumoproteins in HIV: A secondary analysis of a randomized, double blind, study.
    AIDS Res Hum Retroviruses. 2021 Mar 22. doi: 10.1089/AID.2020.0285.
    PubMed     Abstract available


  82. DAHL CM, Miller ES, Leziak K, Jackson J, et al
    Communication between pregnant women and male partners about HIV testing in the United States.
    AIDS Res Hum Retroviruses. 2021 Mar 19. doi: 10.1089/AID.2020.0300.
    PubMed     Abstract available


  83. HERBERTSON EC, Lahiri C, Nwogu JN, Soremekun RO, et al
    High Acceptability of Donating Hair and other Biological Samples for Research Among People Living with HIV in an Outpatient Clinic in Lagos, Nigeria.
    AIDS Res Hum Retroviruses. 2021 Mar 9. doi: 10.1089/AID.2020.0214.
    PubMed     Abstract available


  84. GALAVIZ KI, Schneider MF, Tien PC, Althoff KN, et al
    Expanding the Finnish Diabetes Risk Score for predicting diabetes incidence in people living with HIV.
    AIDS Res Hum Retroviruses. 2021 Mar 8. doi: 10.1089/AID.2020.0247.
    PubMed     Abstract available


  85. BAILEY AJ, Rhee SY, Shafer RW
    Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
    AIDS Res Hum Retroviruses. 2021 Mar 8. doi: 10.1089/AID.2020.0261.
    PubMed     Abstract available


  86. SABERI P, Campbell C, Venegas M, Dube K, et al
    Time to Engage Young People in HIV Cure Research.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0268.
    PubMed     Abstract available


  87. RUDOMETOVA NB, Shcherbakova NS, Shcherbakov DN, Mishenova EV, et al
    Genetic diversity and drug resistance mutations in reverse transcriptase and protease genes of HIV-1 isolates from Southwestern Siberia.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0225.
    PubMed     Abstract available


  88. LOFGREN SM, Nicol MR, Kandole TK, Castillo-Mancilla JR, et al
    A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis.
    AIDS Res Hum Retroviruses. 2021 Mar 7. doi: 10.1089/AID.2020.0202.
    PubMed     Abstract available


  89. GUAN Y, Bai D, Wang C, Liu Y, et al
    Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.
    AIDS Res Hum Retroviruses. 2021;37:171-172.
    PubMed    


    February 2021
  90. JONES DL, Rodriguez VJ, Salazar AS, Montgomerie E, et al
    Sex Differences in the Association Between Stress, Loneliness, and COVID-19 Burden among People with HIV in the US.
    AIDS Res Hum Retroviruses. 2021 Feb 25. doi: 10.1089/AID.2020.0289.
    PubMed     Abstract available


  91. MILIC J, Novella A, Meschiari M, Menozzi M, et al
    Darunavir/cobicistat is associated with negative outcomes in HIV-negative patients with severe COVID-19 pneumonia.
    AIDS Res Hum Retroviruses. 2021 Feb 23. doi: 10.1089/AID.2020.0305.
    PubMed     Abstract available


  92. SMITH K
    Long-acting injectables come of age to change the HIV therapeutic landscape and the lives of persons with HIV.
    AIDS Res Hum Retroviruses. 2021 Feb 19. doi: 10.1089/AID.2021.0037.
    PubMed     Abstract available


  93. PATEL RH, Acharya A, Chand HS, Mohan M, et al
    HIV and SARS-CoV-2 Co-infection: A Systematic Review of the Literature and Challenges.
    AIDS Res Hum Retroviruses. 2021 Feb 18. doi: 10.1089/AID.2020.0284.
    PubMed     Abstract available


  94. DA SILVA AS, Cavalcanti MDSM, Belmont TFM, Ximenes RAA, et al
    The 1G/1G + 1G/2G genotypes of MMP1 rs1799750 are associated with higher levels of MMP-1 and are both associated with lipodystrophy in people living with HIV on antiretroviral therapy?
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0237.
    PubMed     Abstract available


  95. MONTANO M
    PRESSING QUESTIONS AND CHALLENGES IN THE HIV-1 AND SARS-COV-2 SYNDEMIC.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2021.0005.
    PubMed     Abstract available


  96. CICCULLO A, Baldin G, Dusina A, Cossu MV, et al
    Efficacy and safety of dolutegravir plus lamivudine as a first-line regimen in clinical practice.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0276.
    PubMed     Abstract available


  97. WEERASURIA M, Ko C, Ehm A, O'Bryan J, et al
    The impact of the COVID-19 pandemic on people living with HIV in Victoria, Australia.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2021.0007.
    PubMed     Abstract available


  98. TROYANO-HERNAEZ P, Reinosa R, Burgos MC, Holguin A, et al
    Update in natural antiretroviral-associated mutations among HIV-2 variants and discrepancies across HIV-2 resistance interpretation tools.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0180.
    PubMed     Abstract available


  99. CICCULLO A, Baldin G, Borghi V, Lassandro AP, et al
    Lamivudine plus dolutegravir improves bone mineral density compared to emtricitabine/tenofovir alafenamide plus an integrase inhibitor.
    AIDS Res Hum Retroviruses. 2021 Feb 15. doi: 10.1089/AID.2020.0274.
    PubMed     Abstract available


  100. YORK L, Fisher JM, Malladi L, August JA, et al
    Antiretroviral Laboratory Monitoring and Implications for HIV Clinical Care in the Era of COVID-19 and Beyond.
    AIDS Res Hum Retroviruses. 2021 Feb 10. doi: 10.1089/AID.2020.0263.
    PubMed     Abstract available


  101. HU M, Valicherla GR, Zhou T, Hillier SL, et al
    Expression, activity, and regulation of phosphorylating enzymes in tissues and cells relevant to HIV-1 sexual transmission.
    AIDS Res Hum Retroviruses. 2021 Feb 10. doi: 10.1089/AID.2020.0250.
    PubMed     Abstract available


    January 2021
  102. HARIYANTO TI, Putri C, Frinka P, Louisa J, et al
    Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
    AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0307.
    PubMed     Abstract available


  103. GALIWANGO RM, Ssuuna C, Kaleebu P, Kigozi G, et al
    Validation of the Asante HIV-1 Rapid Recency(R) Assay for detection of recent HIV-1 infections in Uganda.
    AIDS Res Hum Retroviruses. 2021 Jan 27. doi: 10.1089/AID.2020.0279.
    PubMed     Abstract available


  104. CHAWANA TD, Nhachi CFB, Nathoo K, Ngara B, et al
    Higher tenofovir concentrations in hair are associated with decreases in viral load and not self-reported adherence in HIV-infected adolescents with second line virological treatment failure.
    AIDS Res Hum Retroviruses. 2021 Jan 26. doi: 10.1089/AID.2020.0258.
    PubMed     Abstract available


  105. DEVANATHAN AS, Kashuba A
    HIV Persistence in the Spleen: Opportunities for Pharmacologic Intervention.
    AIDS Res Hum Retroviruses. 2021 Jan 26. doi: 10.1089/AID.2020.0266.
    PubMed     Abstract available


  106. DI CARLO D, Falasca F, Palermo E, Mezzaroma I, et al
    Dolutegravir-based regimen for maintenance of viral suppression in people living with HIV: 48-week results in real life setting.
    AIDS Res Hum Retroviruses. 2021 Jan 24. doi: 10.1089/AID.2020.0196.
    PubMed     Abstract available


  107. DIEPSTRA KL, Barr L, Palm D, Hogg E, et al
    Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause (IMAP): Results from the AIDS Clinical Trials Group (ACTG) A5345 Biomarker Study.
    AIDS Res Hum Retroviruses. 2021 Jan 20. doi: 10.1089/AID.2020.0222.
    PubMed     Abstract available


  108. ROSSOUW J, Schwartz S, Rao A, Mcingana M, et al
    Exploring the association between depression and social and bio-behavioural HIV risks factors among female sex workers in Nelson Mandela Bay Municipality, South Africa.
    AIDS Res Hum Retroviruses. 2021 Jan 20. doi: 10.1089/AID.2020.0233.
    PubMed     Abstract available


  109. RUHANYA V, Jacobs GB, Naidoo S, Paul RH, et al
    Impact of plasma IP-10/CXCL10 and RANTES/CCL5 levels on neurocognitive function in HIV treatment naive patients.
    AIDS Res Hum Retroviruses. 2021 Jan 20. doi: 10.1089/AID.2020.0203.
    PubMed     Abstract available


  110. HAALAND R, Martin A, Mengesha M, Dinh C, et al
    Evaluation of antiretroviral drug concentrations in minimally invasive specimens for potential development of point of care drug assays.
    AIDS Res Hum Retroviruses. 2021 Jan 18. doi: 10.1089/AID.2020.0187.
    PubMed     Abstract available


  111. MIRANDA AC, Miranda M, Pingarilho M, Pimentel V, et al
    Determinants of HIV-1 late presentation in a cohort of Portuguese HIV-1 patients.
    AIDS Res Hum Retroviruses. 2021 Jan 18. doi: 10.1089/AID.2020.0175.
    PubMed     Abstract available


  112. BERARD AR, Miller C, Arainga M, Broedlow CA, et al
    SIV susceptibility, immunology and microbiome in the female genital tract of adolescent versus adult pigtail macaques.
    AIDS Res Hum Retroviruses. 2021 Jan 15. doi: 10.1089/AID.2020.0271.
    PubMed     Abstract available


  113. LI J, Gao L, Ye Z
    Study of Brain Structure in HIV Vertically Infected Adolescents.
    AIDS Res Hum Retroviruses. 2021 Jan 11. doi: 10.1089/AID.2020.0030.
    PubMed     Abstract available


  114. KOUAMOU V, Mavetera J, Manasa J, Ndhlovu CE, et al
    Pre-treatment HIV Drug Resistance Among Adults Initiating or Re-initiating 1st Line Antiretroviral Therapy in Zimbabwe: Fast-tracking the Transition to Dolutegravir Based 1st Line Regimens?
    AIDS Res Hum Retroviruses. 2021 Jan 11. doi: 10.1089/AID.2020.0242.
    PubMed     Abstract available


  115. BARIK SK, Bansal AK, Mohanty PS, Tripathy SP, et al
    Detection of drug resistance mutations in the reverse transcriptase gene of HIV-1-infected North Indian population failing first line antiretroviral therapy "A follow-up cohort study".
    AIDS Res Hum Retroviruses. 2021 Jan 3. doi: 10.1089/AID.2020.0132.
    PubMed     Abstract available


  116. WANG X, Zhang Y, Liu Y, Li H, et al
    Phylogenetic analysis of sequences in the HIV database revealed multiple potential circulating recombinant forms in China.
    AIDS Res Hum Retroviruses. 2021 Jan 3. doi: 10.1089/AID.2020.0190.
    PubMed     Abstract available


  117. NGALAMIKA O, Munsaka S, Lidenge S, West J, et al
    Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-related, and Sociodemographic Predictors of Outcome.
    AIDS Res Hum Retroviruses. 2021 Jan 1. doi: 10.1089/AID.2020.0099.
    PubMed     Abstract available


  118. ZHAO R, Ding R, Zhang Q
    What are the risk factors for surgical site infection in HIV positive patients receiving open reduction and internal fixation of traumatic limb fractures? A retrospective cohort study.
    AIDS Res Hum Retroviruses. 2021 Jan 1. doi: 10.1089/AID.2020.0184.
    PubMed     Abstract available


    December 2020
  119. AL-KHOUJA A, Shieh EC, Fuchs EJ, Marzinke MA, et al
    Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: a First-in-Human Study.
    AIDS Res Hum Retroviruses. 2020 Dec 28. doi: 10.1089/AID.2020.0188.
    PubMed     Abstract available


  120. GUERRIERO KA, Murnane RD, Lewis TB, Brown B, et al
    Recrudescence of Natural Coccidioidomycosis during Combination Antiretroviral Therapy in a Pigtail Macaque Experimentally Infected with Simian Immunodeficiency Virus.
    AIDS Res Hum Retroviruses. 2020 Dec 23. doi: 10.1089/AID.2020.0228.
    PubMed     Abstract available


  121. MONTANO-CASTELLON I, Zeballos D, Gutierrez-Peredo G, Netto EM, et al
    "High prevalence of frailty and pre-frailty status in Brazilian patients living with HIV".
    AIDS Res Hum Retroviruses. 2020 Dec 22. doi: 10.1089/AID.2020.0113.
    PubMed     Abstract available


  122. RAGONNET-CRONIN M, Benbow N, Hayford C, Poortinga K, et al
    Sorting by race/ethnicity across HIV genetic transmission networks in three major metropolitan areas in the United States.
    AIDS Res Hum Retroviruses. 2020 Dec 21. doi: 10.1089/AID.2020.0145.
    PubMed     Abstract available


  123. KERRIGAN D, Murray M, Sanchez Karver T, Mantsios A, et al
    Feasibility of implementing long-acting injectable anti-retroviral therapy to treat HIV: a survey of health providers from the 13 countries participating in the ATLAS-2M trial.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0208.
    PubMed     Abstract available


  124. SIM JH, Sherman JB, Stanley TL, Corey KE, et al
    Pro-inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0177.
    PubMed     Abstract available


  125. PAPASAVVAS E, Azzoni L, Pagliuzza A, Abdel-Mohsen M, et al
    Safety, immune and anti-viral effects of pegylated interferon alpha 2b administration in ART-suppressed individuals: Results of pilot clinical trial.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0243.
    PubMed     Abstract available


  126. BORGHETTI A, Bellino S, Lombardi F, Whalen M, et al
    Risk of tumour onset in HIV+ patients on two-drug regimens: a cohort study in an Italian hospital.
    AIDS Res Hum Retroviruses. 2020 Dec 15. doi: 10.1089/AID.2020.0087.
    PubMed     Abstract available


  127. MEHTA G, Sharma A, Arora SK
    Acquisition of additional NFkappaB binding sites in LTR of genetically evolving HIV-1 subtype C viral species in host with co-morbidities.
    AIDS Res Hum Retroviruses. 2020 Dec 14. doi: 10.1089/AID.2020.0195.
    PubMed     Abstract available


  128. BEHRENS N, Love M, Bandlamuri M, Bernhardt D, et al
    Characterization of HIV-1 Envelope V3 Region Sequences from Virologically Controlled HIV-Infected Older Patients on Long Term Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0139.
    PubMed     Abstract available


  129. XIE YN, Li SL, Yang RR, Huang J, et al
    Genetic characteristics of three unique recombinant forms of HIV-1 in Yunnan, China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0234.
    PubMed     Abstract available


  130. LAN Y, Li L, Deng X, Cai X, et al
    Near full-length genomic characterization of a novel HIV-1 B/C recombinant form identified in Guangdong Province, China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0278.
    PubMed     Abstract available


  131. ZHU G, Han J, Li H, Liu Y, et al
    Near full-length Genomic Characterization of 16 HIV-1 CRF01_AE Primary Isolates from Guangxi, China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0277.
    PubMed     Abstract available


  132. PENG X, Xu Y, Wu N
    Beijing as the hub of CRF07_BC transmission from the intravenous drug users to men who have sex with men in China.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0147.
    PubMed     Abstract available


  133. SNO R, Labadie-Bracho MY, Grunberg MG, Adhin MR, et al
    First Assessment of Acquired HIV-1 Drug Resistance and Mutation Patterns in Suriname.
    AIDS Res Hum Retroviruses. 2020 Dec 7. doi: 10.1089/AID.2020.0194.
    PubMed     Abstract available


  134. BALDIN G, Ciccullo A, Lombardi F, D'Angelillo A, et al
    Comparing lamivudine+dolutegravir and bictegravir/emtricitabine/tenofovir alafenamide as switch strategies: preliminary results from clinical practice.
    AIDS Res Hum Retroviruses. 2020 Dec 5. doi: 10.1089/AID.2020.0219.
    PubMed     Abstract available



  135. Correction to: Systemic Mitochondrial Oxidative Phosphorylation Protein Levels Correlate with Neuroimaging Measures in Chronically HIV-Infected Individuals by Kallianpur KJ, et al. AIDS Res Hum Retroviruses 2020;36(1):83-91 DOI:10.1089/aid.2019.0240.
    AIDS Res Hum Retroviruses. 2020;36:1083.
    PubMed    



  136. Call for Special Issue Papers: Special Issue on Coronaviruses as a Co-Morbidity of HIV Infection.
    AIDS Res Hum Retroviruses. 2020;36:965-966.
    PubMed    


    November 2020
  137. MEHTA G, Sharma A, Arora SK
    Human Immunodeficiency virus-1 (HIV-1) subtype-C genetically diversify to acquire higher replication competence in human host with co-morbid conditions.
    AIDS Res Hum Retroviruses. 2020 Nov 25. doi: 10.1089/AID.2020.0118.
    PubMed     Abstract available


  138. HUSSAIN S, Golozar A, Widney DP, Rappocciolo G, et al
    Effect of statin use on inflammation and immune activation biomarkers in HIV-infected persons on effective anti-retroviral therapy.
    AIDS Res Hum Retroviruses. 2020 Nov 25. doi: 10.1089/AID.2020.0127.
    PubMed     Abstract available


  139. LAHIRI C, Xu Y, Wang K, Alvarez JA, et al
    Weight and body mass index change after switching to integrase inhibitors or tenofovir alafenamide among women living with HIV.
    AIDS Res Hum Retroviruses. 2020 Nov 24. doi: 10.1089/AID.2020.0197.
    PubMed     Abstract available


  140. HAANKUKU UN, Njuho PM
    The estimation of transmitted drug resistance mutation strains probability in the treatment of HIV using the beta-binomial model.
    AIDS Res Hum Retroviruses. 2020 Nov 16. doi: 10.1089/AID.2020.0166.
    PubMed     Abstract available


  141. IBRAHIM ME, Castillo-Mancilla JR, Yager J, Brooks KM, et al
    Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis.
    AIDS Res Hum Retroviruses. 2020 Nov 15. doi: 10.1089/AID.2020.0108.
    PubMed     Abstract available


  142. SENEVIRATNE HK, Tillotson J, Lade JM, Bekker LG, et al
    Metabolism of Long-Acting Rilpivirine Following Intramuscular Injection: HIV Prevention Trials Network Study 076 (HPTN 076).
    AIDS Res Hum Retroviruses. 2020 Nov 15. doi: 10.1089/AID.2020.0155.
    PubMed     Abstract available


  143. PENG X, Xu Y, Huang Y, Zhu B, et al
    Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure.
    AIDS Res Hum Retroviruses. 2020 Nov 15. doi: 10.1089/AID.2020.0213.
    PubMed     Abstract available


  144. KANAZAWA JT, Saberi P, Sauceda JA, Dube K, et al
    The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.
    AIDS Res Hum Retroviruses. 2020 Nov 11. doi: 10.1089/AID.2020.0126.
    PubMed     Abstract available


  145. BABU H, Rachel G, Hanna LE
    Alterations in Circulating Metabolites with Neuroinflammatory Property and Their Impact on Neurological Function in HIV-1-Infected Individuals on Long-Term Suppressive cART.
    AIDS Res Hum Retroviruses. 2020 Nov 10. doi: 10.1089/aid.2020.0218.
    PubMed    


  146. HOPE T
    Call for Special Issue Papers: Special Issue on Coronaviruses as a Co-Morbidity of HIV Infection.
    AIDS Res Hum Retroviruses. 2020;36:i-ii.
    PubMed    


    October 2020
  147. PARKER I, Khalil G, Martin A, Martin MT, et al
    Altered Antibody Responses in Persons Infected with HIV-1 While Using PrEP.
    AIDS Res Hum Retroviruses. 2020 Oct 30. doi: 10.1089/AID.2020.0137.
    PubMed     Abstract available


  148. HADJIKOU A, Pavlopoulou ID, Pantavou K, Georgiou AN, et al
    Drug injection-related norms and high-risk behaviors of people who inject drugs in Athens, Greece.
    AIDS Res Hum Retroviruses. 2020 Oct 30. doi: 10.1089/AID.2020.0050.
    PubMed     Abstract available


  149. CALZA L, Borderi M, Colangeli V, Testi D, et al
    NO SIGNIFICANT CHANGES IN WEIGHT AND BODY FAT MASS IN SUPPRESSED HIV-INFECTED PATIENTS SWITCHED TO DUAL COMBINATION LAMIVUDINE PLUS DOLUTEGRAVIR OR RALTEGRAVIR.
    AIDS Res Hum Retroviruses. 2020 Oct 30. doi: 10.1089/AID.2020.0117.
    PubMed     Abstract available


  150. SRINIVASAN R, Padmapriyadarsini C, Ramesh K, Sanjeeva GN, et al
    APOC3 Gene polymorphism and ART-induced dyslipidemia in HIV Infected Children.
    AIDS Res Hum Retroviruses. 2020 Oct 29. doi: 10.1089/AID.2020.0082.
    PubMed     Abstract available


  151. PAREDES R, Veliz F, Lucchetti AJ
    Comparison of the virological response according to the antiretroviral regimens in Peruvian HIV patients who presented the M184V mutation in two national hospitals during the years 2008 to 2019.
    AIDS Res Hum Retroviruses. 2020 Oct 20. doi: 10.1089/AID.2020.0115.
    PubMed     Abstract available


  152. ADENIYI OV, Obi CL, Goon DT, Iweriebor B, et al
    Genetic Characterization of HIV-1 Subtype A1/C/D/B/K Unique Recombinant Form from Eastern Cape, South Africa.
    AIDS Res Hum Retroviruses. 2020 Oct 20. doi: 10.1089/AID.2020.0160.
    PubMed     Abstract available


  153. GHOSN J, Abdoul H, Fellahi S, Merlet A, et al
    Prevalence of silent atherosclerosis and other comorbidities in an outpatient cohort of adults living with HIV: associations with HIV parameters and biomarkers.
    AIDS Res Hum Retroviruses. 2020 Oct 20. doi: 10.1089/AID.2020.0182.
    PubMed     Abstract available


  154. MEISSNER EG, Chung D, Tsao B, Haas D, et al
    IFNL4 Genotype Does Not Associate with CD4 T-Cell Recovery in Persons Living with HIV.
    AIDS Res Hum Retroviruses. 2020 Oct 16. doi: 10.1089/AID.2020.0104.
    PubMed     Abstract available


  155. JACOBSON D, Liu JZ, Lindsey JC, Shiau S, et al
    Immune markers and their association with bone density in children, adolescents and young adults with perinatally-acquired HIV.
    AIDS Res Hum Retroviruses. 2020 Oct 16. doi: 10.1089/AID.2020.0171.
    PubMed     Abstract available


  156. STAITIEH BS, Auld SC, Ahmed M, Fan X, et al
    GM-CSF Reverses HIV Protein-Induced Mitochondrial Derangements in Alveolar Macrophages.
    AIDS Res Hum Retroviruses. 2020 Oct 15. doi: 10.1089/AID.2020.0176.
    PubMed     Abstract available


  157. HOPE TJ, Klatt NR, Sacha JB, Cannon P, et al
    Timothy Ray Brown: The Serendipitous Hero of HIV Cure Research.
    AIDS Res Hum Retroviruses. 2020 Oct 14. doi: 10.1089/AID.2020.0253.
    PubMed     Abstract available


  158. DIALLO MS, Samri A, Charpentier C, Bertine M, et al
    A comparison of cell activation, exhaustion and expression of HIV co-receptors and restriction factors in HIV-1 and HIV-2 infected Non Progressors.
    AIDS Res Hum Retroviruses. 2020 Oct 14. doi: 10.1089/AID.2020.0084.
    PubMed     Abstract available


  159. DABITAO D, Dembele M, Urbanowski M, Kone B, et al
    Genetic variation in human IL10 proximal promoter and susceptibility to HIV-1 infection in Mali, West Africa.
    AIDS Res Hum Retroviruses. 2020 Oct 12. doi: 10.1089/AID.2020.0140.
    PubMed     Abstract available


  160. HEINSON AI, Woo J, Mukim A, White CH, et al
    Micro RNA targets in HIV latency - insights into novel layers of latency control.
    AIDS Res Hum Retroviruses. 2020 Oct 12. doi: 10.1089/AID.2020.0150.
    PubMed     Abstract available


  161. CHEW G, Padua AJ, Chow D, Souza SA, et al
    Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T cell Responses to PD-L1 Blockade.
    AIDS Res Hum Retroviruses. 2020 Oct 6. doi: 10.1089/AID.2020.0172.
    PubMed     Abstract available


  162. LOUTFY M, Varriano B, Crouzat F, Sandler I, et al
    Cardiovascular events in an inner-city HIV clinic and relation to abacavir- vs. TDF- containing antiretroviral regimens.
    AIDS Res Hum Retroviruses. 2020 Oct 6. doi: 10.1089/AID.2020.0053.
    PubMed     Abstract available


    September 2020
  163. CICCULLO A, Baldin G, Borghi V, Sterrantino G, et al
    Overall tolerability of Integrase Inhibitors in clinical practice: results from a multicenter Italian cohort.
    AIDS Res Hum Retroviruses. 2020 Sep 30. doi: 10.1089/AID.2020.0078.
    PubMed     Abstract available


  164. ABBAS AL, Marcusso R, Penalva AC, de Almeida VP, et al
    HTLV-1 Versus HIV: 40 years of Challenges from Discovery to Treatment for Human Retroviruses and Neurological Implications.
    AIDS Res Hum Retroviruses. 2020 Sep 30. doi: 10.1089/AID.2020.0210.
    PubMed     Abstract available


  165. WILLIAMS ME, Fielding BC
    Insult to injury- potential contribution of COVID-19 to neuroinflammation and the development of HIV-associated neurocognitive disorders.
    AIDS Res Hum Retroviruses. 2020 Sep 30. doi: 10.1089/AID.2020.0136.
    PubMed     Abstract available


  166. GUTHRIE KM, Fava JL, Vargas S, Rosen RK, et al
    The role of volume in the perceptibility of topical vaginal formulations: User sensory perceptions and experiences (USPEs) of heterosexual couples during vaginal sex.
    AIDS Res Hum Retroviruses. 2020 Sep 29. doi: 10.1089/AID.2020.0138.
    PubMed     Abstract available


  167. HAESELEER F, Eichholz K, Tareen SU, Iwamoto N, et al
    Real-time killing assays to assess the potency of a new anti-SIV CAR.
    AIDS Res Hum Retroviruses. 2020 Sep 29. doi: 10.1089/AID.2020.0163.
    PubMed     Abstract available



  168. Retraction of: Association Between Polymorphisms in the Interleukin-10 Gene and Susceptibility to HIV-1 Infection," by Dan-Hui Fu, Wen-Juan Deng, Zhi Yang, Sen Hong, Qian-Ling Ding, Yang Zhao, Jia Chen, and Dan-Ke Su; AIDS Res Hum Retroviruses, epub:
    AIDS Res Hum Retroviruses. 2020 Sep 28. doi: 10.1089/aid.2020.0011.
    PubMed    


  169. WANG Y, Wen Y
    An AIDS Patient with Recurrent Multiple Skin Crusted Ulcerations.
    AIDS Res Hum Retroviruses. 2020 Sep 28. doi: 10.1089/AID.2020.0212.
    PubMed     Abstract available


  170. YIN Y, Zhou Y, Lu J, Liu X, et al
    Molecular epidemiology of HIV-1 in Jiangsu province, Southeast of China: genotypes and HIV-1 transmission networks among newly diagnosed MSM in 2017.
    AIDS Res Hum Retroviruses. 2020 Sep 24. doi: 10.1089/AID.2020.0165.
    PubMed     Abstract available


  171. HE S, Gao Y, An M, Zhao B, et al
    Characterization of a Novel HIV-1 CRF01_AE/CRF07_BC Recombinant Strain among Men Who Have Sex with Men in Liaoning, China.
    AIDS Res Hum Retroviruses. 2020 Sep 24. doi: 10.1089/AID.2020.0223.
    PubMed     Abstract available


  172. TAVARES A, Pingarilho M, Batista J, Viveiros M, et al
    HIV and tuberculosis co-infection among migrants in Portugal: a brief study on their sociodemographic, clinical, and genomic characteristics.
    AIDS Res Hum Retroviruses. 2020 Sep 22. doi: 10.1089/AID.2020.0119.
    PubMed     Abstract available


  173. CHAUDHARY O, Wang L, Bose D, Narayan V, et al
    Comparative evaluation of prophylactic SIV vaccination modalities administered to the oral cavity.
    AIDS Res Hum Retroviruses. 2020 Sep 22. doi: 10.1089/AID.2020.0157.
    PubMed     Abstract available


  174. HARVILLA N, Bhat P, Koka M, Riedel DJ, et al
    Disseminated Mycobacterium avium complex in an HIV-infected with diffuse lymphadenopathy.
    AIDS Res Hum Retroviruses. 2020 Sep 17. doi: 10.1089/AID.2020.0130.
    PubMed     Abstract available


    April 2020
  175. BROWN TR
    The London Patient.
    AIDS Res Hum Retroviruses. 2020;36:251-252.
    PubMed    


  176. GUIMARAES MDC
    Caution on the Interpretation of Respondent-Driven Sampling Results.
    AIDS Res Hum Retroviruses. 2020;36:253.
    PubMed    


    February 2020
  177. AUGIER C, Beyne E, Villabona-Arenas CJ, Mpoudi Ngole E, et al
    Identification of a Novel Simian Immunodeficiency Virus-Infected African Green Monkey (Chlorocebus tantalus) Confirms that Tantalus Monkeys in Cameroon Are Infected with a Mosaic SIVagm Lineage.
    AIDS Res Hum Retroviruses. 2020;36:167-170.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: